Logo

Variagenics Patents SNP Discovery Method

Jun 06, 2002

NEW YORK, June 6-Variagenics said today that it has been granted a U.S. patent for its computational method for SNP identification.

 

The patent, granted June 4, covers Variagenics' proprietary technique for discovering unknown polymorphisms in genes that appear to be relevant to disease. Their "sequence scanning" method allows company researchers to more easily distinguish SNPs from sequence data.

 

Variagenics, based in Cambridge, Mass., is a pharmacogenomic and diagnostic company. It plans to use the data generated from its SNP studies in improving drug development and creating new pharmacogenomic diagnostics.

 

For more information, see the patent.

Breaking News
The Scan

Fertility Fraud Found

Consumer genetic testing has uncovered cases of fertility fraud that are leading to lawsuits, according to USA Today.

Ties Between Vigorous Exercise, ALS in Genetically At-Risk People

Regular strenuous exercise could contribute to motor neuron disease development among those already at genetic risk, Sky News reports.

Test Warning

The Guardian writes that the US regulators have warned against using a rapid COVID-19 test that is a key part of mass testing in the UK.

Science Papers Examine Feedback Mechanism Affecting Xist, Continuous Health Monitoring for Precision Medicine

In Science this week: analysis of cis confinement of the X-inactive specific transcript, and more.